Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Regeneron

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.

regeneron

Regeneron and Teva close gap on rivals with NGF pain drug

Regeneron and Teva close gap on rivals with NGF pain drug

Regeneron and Teva’s nerve growth factor (NGF) inhibitor fasinumab hit the mark in a phase III osteoarthritis trial, potentially setting up a race to the finish line in the ... Earlier this year, Regeneron also revealed it had halted a high-dose arm in

US insurers can peg access to ICER value reviews

US insurers can peg access to ICER value reviews Sanofi/Regeneron, GlaxoSmithKline’s severe asthma therapy Nucala (mepolizumab) and Vertex’range of cystic fibrosis drugs.

Regeneron and Bluebird sign $100m cell therapies deal

Regeneron and Bluebird sign $100m cell therapies deal Regeneron and Bluebird sign $100m cell therapies deal. Six targets chosen from TCR and other cell therapy platforms. ... If Regeneron does not opt-in, the company is eligible to receive milestone payments and royalties from Bluebird on any potential

Dupixent bounce-back helps stem diabetes declines at Sanofi

Dupixent bounce-back helps stem diabetes declines at Sanofi Leading the charge in the specialty care category this quarter was Regeneron-partnered Dupixent (dupilumab), which has had a lumpy start since its launch last year with first quarter sales dipping ... Another Regeneron-partnered drug – and another key

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics